WOC
TMO icon

West Oak Capital’s Thermo Fisher Scientific TMO Stock Holding History

West Oak Capital’s Portfolio TMO Stock Details TMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-95
Closed -$473 – 316
2025
Q1 		$473 Sell
95
-125
-57% -$67.7K 0.02% 174
2024
Q4 		$1.15M Hold
220
– – 0.04% 137
2024
Q3 		$1.36K Hold
220
– – 0.03% 135
2024
Q2 		$122K Sell
220
-25
-10% -$14.3K 0.05% 144
2024
Q1 		$142K Sell
245
-385
-61% -$216K 0.06% 141
2023
Q4 		$343K Sell
630
-75
-11% -$36.3K 0.16% 94
2023
Q3 		$357K Sell
705
-50
-7% -$26.6K 0.18% 88
2023
Q2 		$394K Sell
755
-180
-19% -$97.1K 0.19% 87
2023
Q1 		$539K Buy
935
+115
+14% +$64.8K 0.27% 78
2022
Q4 		$452K Buy
820
+50
+6% +$26.5K 0.24% 80
2022
Q3 		$391K Buy
770
+545
+242% +$305K 0.21% 81
2022
Q2 		$122K Hold
225
– – 0.06% 135
2022
Q1 		$133K Sell
225
-20
-8% -$11.5K 0.06% 140
2021
Q4 		$163K Hold
245
– – 0.06% 135
2021
Q3 		$140K Hold
245
– – 0.05% 141
2021
Q2 		$124K Buy
245
+45
+23% +$21.2K 0.05% 147
2021
Q1 		$91K Hold
200
– – 0.04% 156
2020
Q4 		$93K Buy
200
+25
+14% +$11.7K 0.04% 147
2020
Q3 		$77K Buy
+175
New +$72.3K 0.04% 146
2016
Q4 		– Sell
-29
Closed -$4.61K – 375
2016
Q3 		$4.61K Buy
+29
New +$4.47K ﹤0.01% 322

Other funds holding TMO

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

West Oak Capital's TMO Position: Q2 2025 in Review

West Oak Capital sold out of Thermo Fisher Scientific (TMO) in Q2 2025, closing a stake of 95 shares — an estimated $473 sold.

West Oak Capital first reported a position in TMO in Q3 2016 and held it in 20 quarters. The position peaked at $1.15M in Q4 2024. 2,454 funds tracked by Wall St. Rank hold TMO as of Q2 2025.

  • West Oak Capital reported no remaining Thermo Fisher Scientific position as of Q2 2025 after selling out during the quarter.
  • West Oak Capital sold 95 Thermo Fisher Scientific shares in Q2 2025, an estimated $473.
  • West Oak Capital first reported a position in Thermo Fisher Scientific in Q3 2016 and held it in 20 quarters.
  • West Oak Capital's Thermo Fisher Scientific position peaked at $1.15M in Q4 2024.
  • 2,454 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2025.

Based on West Oak Capital's 13F filing for Q2 2025, filed 15 Jul 2025.